title: Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells.
abstract: Apoptotic cells contain nuclear autoantigens that may initiate a systemic autoimmune response. To explore the mechanism of antibody binding to apoptotic cells, 3H9, a murine autoantibody with dual specificity for phospholipids and DNA, was used. H chain mutants of 3H9 were constructed, expressed as single-chain Fv (scFv) in Escherichia coli, and assessed for binding to phosphatidylserine, an antigen expressed on apoptotic cells. Both 3H9 and its germline revertant bound to dioleoyl phosphatidylserine in ELISA, and binding was enhanced by beta 2 glycoprotein I (beta 2GPI), a plasma protein that selectively binds to apoptotic cells. Higher relative affinity for DOPS-beta 2GPI was achieved by the introduction of Arg residues into the 3H9 H chain variable region at positions previously shown to mediate DNA binding. Specificity of the two structurally most diverse scFv for apoptotic cells was shown by flow cytometry, and two populations of scFv-bound cells were identified by differences in propidium iodide staining. The results suggest that, in autoimmunity, B cells with Ig receptors for apoptotic cells and DNA are positively selected, and that the antibodies they produce have the potential to affect the clearance and processing of apoptotic cells.
authors.affiliation: Department of Microbiology and Immunology, MCP Hahnemann University, Philadelphia, PA 19129, USA.
authors.forename: B A
authors.initials: BA
authors.lastname: Cocca
authors.forename: S N
authors.initials: SN
authors.lastname: Seal
authors.forename: P
authors.initials: P
authors.lastname: D'Agnillo
authors.forename: Y M
authors.initials: YM
authors.lastname: Mueller
authors.forename: P D
authors.initials: PD
authors.lastname: Katsikis
authors.forename: J
authors.initials: J
authors.lastname: Rauch
authors.forename: M
authors.initials: M
authors.lastname: Weigert
authors.forename: M Z
authors.initials: MZ
authors.lastname: Radic
mesh_terms: D000595:Amino Acid Sequence; D000974:Antibodies, Antinuclear / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D017152:Antibodies, Antiphospholipid / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D017209:Apoptosis / Q000276:immunology*; D004247:DNA / Q000276:immunology; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D007128:Immunoglobulin Fragments / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D007143:Immunoglobulin Heavy Chains / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D007135:Immunoglobulin Variable Region / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D019169:Jurkat Cells; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010718:Phosphatidylserines / Q000276:immunology*; D017434:Protein Structure, Tertiary; D053482:beta 2-Glycoprotein I
chemical_list: C442826:3H9 protein, mouse; D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid; D006023:Glycoproteins; D007128:Immunoglobulin Fragments; D007143:Immunoglobulin Heavy Chains; D007135:Immunoglobulin Variable Region; D010718:Phosphatidylserines; D053482:beta 2-Glycoprotein I; C055966:immunoglobulin Fv; C042511:1,2-dioleoylphosphatidylserine; D004247:DNA